Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
284
result was found. Results that relate to
Drug
Monitoring of trough concentration of mycophenolic acid in plasma of patients with systemic lupus erthematosus by LC-MS/MS
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):67-73.
5677 times
1155 times
Xi-Ping LI
Heng-Yi YU
Dong XIANG
Dong LIU
Xue-Peng GONG
Mycophenolic acid
LC-MS/MS
Therapeutic
drug
monitoring
Systemic lupus erythematosus
Details
Research and pharmaceutical services by clinical pharmacists on antibiotic-related drug interaction in ICU
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):125-1131.
5243 times
1049 times
Hai-Tao WANG
Kang-Huai ZHANG
Jiao XIE
Na WANG
Qian-Ting YANG
Yan CAI
You-Jia LI
Li ZHANG
Yan WANG
Antimicrobial agents
Potential
drug
-antimicrobial agent interactions
Intensive care unit
Pharmaceutical intervention
Details
A case of acute renal injury caused by improper administration of valaciclovir tablets
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):136-139.
6812 times
1604 times
Meng-Meng WANG
Fei HAO
Yan-Ni ZHANG
Valaciclovir
Acute kidney injury
Irrational
drug
use
Adverse
drug
reaction
Details
A case analysis of pancreatitis caused by dulaglutide
Published on
Frontiers in Pharmaceutical Sciences
2023,36(10):140-144.
6745 times
1246 times
Di HUAN
Jing MA
Zi-Jing WU
Jia-Hui LI
Rui WANG
Wen-Xiang LI
Dulaglutide
Pancreatitis
Adverse
drug
reactions
Glucagon like peptide-1 receptor agonist
Details
Evaluation of the rationality of prophylactic antibiotics in perioperative period for cesarean section before and after clinical pharmacists intervention based on entropy weight TOPSIS method
Published on
Journal of Mathematical Medicine
2023,36(11):818-823.
6604 times
1379 times
Nan LI
Wei LIU
Yan-Zhong ZHANG
Antibacterial
drug
s
Cesarean section
Perioperative period
TOPSIS
Clinical pharmacist
Rational
drug
use
Details
Data mining for hypertension associated with VEGFR-TKIs: based on FAERS database
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1201-1208.
6590 times
1548 times
Xiao-Lan LIAO
Jia-Qi GE
Hai-Bin ZHU
Ting-Ting WU
Chun-Xia REN
Zi-Cheng YU
Vascular endothelial growth factor receptor-tyrosine kinase inhibitors
Hypertension
Adverse
drug
events
Pharmacovigilance
FAERS database
Details
Poly ADP-ribose polymerase inhibitor-induced thrombocytopenia: recent advances in pathogenesis and treatments
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1209-1216.
6179 times
1433 times
Ying-Chen ZHUO
Su-Ya ZHANG
Peng-Fei SONG
Wei-Yi FENG
Poly ADP-ribose polymerase inhibitor
Thrombocytopenia
Ovarian cancer
Adverse
drug
reaction
Details
Practice and reflection of pharmacovigilance system construction
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1217-1224.
7899 times
1907 times
Na WANG
Kang-Huai ZHANG
Pharmacovigilance
Drug
use safety
Risk prevention and control
Adverse
drug
reaction
Medication error
Details
Clinical practice of drug abnormal early warning based on dynamic monitoring of clinical pharmacists
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1225-1230.
6511 times
1621 times
Ting-Ting ZHENG
Jin LI
Lu MAO
Ning CHEN
Wei ZHANG
Jian-Cun ZHEN
Rational
drug
use
Abnormal early warning
Dynamic monitoring
Clinical pharmacist
Details
A retrospective study on the safety of off-indication use of pyrotinib in patients with non-small cell lung cancer
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1238-1242.
5974 times
1536 times
Hao-Chun TANG
Jun MENG
Zheng-Zheng XIA
Ling-Zhi REN
Non-small cell lung cancer
Pyrotinib
Adverse
drug
reaction
Safety
Off-indication
Details
A retrospective study of potential drug-drug interactions of dabigatran etexilate in a tertiary hospital
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1243-1249.
6217 times
1593 times
An-Hua WEI
Wen-Jing LI
Yan HUANG
Dabigatran etexilate
Potential
drug
-
drug
interactions
Safety
Retrospective study
Details
Analysis of clinical features of tacrolimus induced acute pancreatitis based on literature cases
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1285-1295.
5722 times
2013 times
Chao YE
Xin LI
Li-Hua LIU
Xin HE
Shen-Jue CHEN
Juan WANG
Tacrolimus
Acute pancreatitis
Case report
Adverse
drug
reactions
Literature analysis
Details
National competent authority regulation and practice of drug benefit-risk communication in the United States, European Union and China
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(1):19-27.
7329 times
1933 times
ZHANG Yinan
WU Tingxi
ZHAO Zhigang
Drug
benefit-risk communication
Safety communication
Drug
safety information
Pharmacovigilance
Details
A case of severe immune-related ulcerative colitis caused by pembrolizumab
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1311-1315.
6820 times
1493 times
Jin-Jin ZOU
Ji-Liang ZHANG
Ni LI
Ding-Yi LIU
Pembrolizumab
Lung squamous cell carcinoma
Severe immune-related ulcerative colitis
Adverse
drug
reactions
Details
A case of sudden cardio arrest caused by oxaliplatin injection
Published on
Chinese Journal of Pharmacoepidemiology
2023,32(11):1316-1320.
6036 times
1580 times
Ying WANG
Qin-Yong SHEN
Shan HUANG
Bing LIN
Ai-Wen HUANG
Oxaliplatin
Sudden cardio arrest
Allergic reaction
Adverse
drug
reaction
Details
上一页
1
2
3
4
5
6
7
8
9
10
18
19
下一页